1887

Journal of General Virology header logo

Volume 96, Issue 12

Genetic polymorphisms of the human cytomegalovirus gene in colorectal cancer and its association with clinical outcome Free

Abstract

Human cytomegalovirus (HCMV) has been increasingly detected in colorectal cancer (CRC), and genetic polymorphisms in HCMV affect its pathogenesis. This study aimed to investigate HCMV genetic polymorphisms in CRC and its correlation with the clinical outcomes. We performed PCR and sequencing of a viral immunomodulatory gene, , in clinical isolates and CRC specimens. The nucleotide and amino acid sequences were aligned, and a phylogenetic tree was constructed. The clinical, pathological and survival data were compared among tumours with different genotypes. HCMV was detected in 49 (47.8 %) of the tumour specimens. Genotype A predominated in 43 samples (22/43; 51.2 %) with successful sequencing, followed by genotype B (13/43; 30.2 %) and genotype C (8/43; 18.6 %). The genotypic distribution was similar to that of the clinical isolates and those reported in other Asian populations. The amino acid sequence of genotype B was the most conserved. For stage II and III CRC patients with HCMV-positive tumours, disease-free survival (DFS) varied among the three major genotypes ( = 0.0046). The presence of genotype B virus in the tumours was associated with a shorter DFS and independently predicted tumour recurrence in a multivariate Cox proportional hazards model (hazard ratio, 5.79; 95 % confidence interval, 1.30–25.81;  = 0.021). By reverse transcription PCR, tumour samples with genotype B viruses had the highest rate of expression. Our results suggest that genetic polymorphisms of HCMV are associated with clinical outcome in CRC and that HCMV may play an immunomodulatory role in the tumour microenvironment of CRC.

  • Received:
  • Accepted:
  • Published Online:
© 2015 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000308
2015-12-01
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/12/3613.html?itemId=/content/journal/jgv/10.1099/jgv.0.000308&mimeType=html&fmt=ahah

References

  1. Arav-Boger R., Willoughby R. E., Pass R. F., Zong J. C., Jang W. J., Alcendor D., Hayward G. S. 2002; Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-α and β-chemokine receptors in congenital CMV disease. J Infect Dis 186:1057–1064 [View Article][PubMed]
     [Google Scholar]
  2. Arav-Boger R., Battaglia C. A., Lazzarotto T., Gabrielli L., Zong J. C., Hayward G. S., Diener-West M., Landini M. P. 2006; Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis 194:464–473 [View Article][PubMed]
     [Google Scholar]
  3. Bale J. F. Jr, Petheram S. J., Robertson M., Murph J. R., Demmler G. 2001; Human cytomegalovirus a sequence and UL144 variability in strains from infected children. J Med Virol 65:90–96 [View Article][PubMed]
     [Google Scholar]
  4. Benedict C. A., Butrovich K. D., Lurain N. S., Corbeil J., Rooney I., Schneider P., Tschopp J., Ware C. F. 1999; Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 162:6967–6970[PubMed]
     [Google Scholar]
  5. Castillo J. P., Kowalik T. F. 2002; Human cytomegalovirus immediate early proteins and cell growth control. Gene 290:19–34 [View Article][PubMed]
     [Google Scholar]
  6. Chen H. P., Lin J. C., Yang S. P., Lan Y. C., Weng W. S., Tsai C. H., Ho D. M., Liu C. Y., Cho W. L., Chan Y. J. 2008; The type-2 variant of human cytomegalovirus glycoprotein N (gN-2) is not the rarest in the Chinese population of Taiwan: influence of primer design. J Virol Methods 151:161–164 [View Article][PubMed]
     [Google Scholar]
  7. Chen H. P., Jiang J. K., Chen C. Y., Chou T. Y., Chen Y. C., Chang Y. T., Lin S. F., Chan C. H., Yang C. Y., other authors. 2012; Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: a quantitative and histological analysis. J Clin Virol 54:240–244 [View Article][PubMed]
     [Google Scholar]
  8. Chen H. P., Jiang J. K., Lai P. Y., Chen C. Y., Chou T. Y., Chen Y. C., Chan C. H., Lin S. F., Yang C. Y., other authors. 2014; Tumoral presence of human cytomegalovirus is associated with shorter disease-free survival in elderly patients with colorectal cancer and higher levels of intratumoral interleukin-17. Clin Microbiol Infect 20:664–671 [View Article][PubMed]
     [Google Scholar]
  9. Cheung T. C., Humphreys I. R., Potter K. G., Norris P. S., Shumway H. M., Tran B. R., Patterson G., Jean-Jacques R., Yoon M., other authors. 2005; Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc Natl Acad Sci U S A 102:13218–13223 [View Article][PubMed]
     [Google Scholar]
  10. Cinatl J. Jr, Cinatl J., Vogel J. U., Rabenau H., Kornhuber B., Doerr H. W. 1996; Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology 39:259–269[PubMed]
     [Google Scholar]
  11. Cinatl J. Jr, Vogel J. U., Kotchetkov R., Wilhelm Doerr H. 2004; Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression. FEMS Microbiol Rev 28:59–77 [View Article][PubMed]
     [Google Scholar]
  12. Dimberg J., Hong T. T., Skarstedt M., Löfgren S., Zar N., Matussek A. 2013; Detection of cytomegalovirus DNA in colorectal tissue from Swedish and Vietnamese patients with colorectal cancer. Anticancer Res 33:4947–4950[PubMed]
     [Google Scholar]
  13. Evans C., Dalgleish A. G., Kumar D. 2006; Review article: immune suppression and colorectal cancer. Aliment Pharmacol Ther 24:1163–1177 [View Article][PubMed]
     [Google Scholar]
  14. Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pagès C., Tosolini M., Camus M., Berger A., other authors. 2006; Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960–1964 [View Article][PubMed]
     [Google Scholar]
  15. Harkins L., Volk A. L., Samanta M., Mikolaenko I., Britt W. J., Bland K. I., Cobbs C. S. 2002; Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360:1557–1563 [View Article][PubMed]
     [Google Scholar]
  16. Heo J., Petheram S., Demmler G., Murph J. R., Adler S. P., Bale J., Sparer T. E. 2008; Polymorphisms within human cytomegalovirus chemokine (UL146/UL147) and cytokine receptor genes (UL144) are not predictive of sequelae in congenitally infected children. Virology 378:86–96 [View Article][PubMed]
     [Google Scholar]
  17. Lurain N. S., Kapell K. S., Huang D. D., Short J. A., Paintsil J., Winkfield E., Benedict C. A., Ware C. F., Bremer J. W. 1999; Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. J Virol 73:10040–10050[PubMed]
     [Google Scholar]
  18. Mao Z. Q., Huang Y., Sun M., Ruan Q., Qi Y., He R., Huang Y. J., Ma Y. P., Ji Y. H., other authors. 2007; Genetic polymorphism of UL144 open reading frame of human cytomegalovirus DNA detected in colon samples from infants with Hirschsprung's disease. World J Gastroenterol 13:4350–4354[PubMed] [CrossRef]
     [Google Scholar]
  19. Michaelis M., Baumgarten P., Mittelbronn M., Driever P. H., Doerr H. W., Cinatl J., Jr. 2011; Oncomodulation by human cytomegalovirus: novel clinical findings open new roads. Med Microbiol Immunol (Berl) 200:1–5 [View Article][PubMed]
     [Google Scholar]
  20. Murayama T., Takegoshi M., Tanuma J., Eizuru Y. 2005; Analysis of human cytomegalovirus UL144 variability in low-passage clinical isolates in Japan. Intervirology 48:201–206 [View Article][PubMed]
     [Google Scholar]
  21. Pagès F., Berger A., Camus M., Sanchez-Cabo F., Costes A., Molidor R., Mlecnik B., Kirilovsky A., Nilsson M., other authors. 2005; Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353:2654–2666 [View Article][PubMed]
     [Google Scholar]
  22. Picone O., Costa J. M., Chaix M. L., Ville Y., Rouzioux C., Leruez-Ville M. 2005; Human cytomegalovirus UL144 gene polymorphisms in congenital infections. J Clin Microbiol 43:25–29 [View Article][PubMed]
     [Google Scholar]
  23. Pignatelli S., Dal Monte P., Rossini G., Chou S., Gojobori T., Hanada K., Guo J. J., Rawlinson W., Britt W., other authors. 2003; Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol 84:647–655 [View Article][PubMed]
     [Google Scholar]
  24. Pignatelli S., Lazzarotto T., Gatto M. R., Dal Monte P., Landini M. P., Faldella G., Lanari M. 2010; Cytomegalovirus gN genotypes distribution among congenitally infected newborns and their relationship with symptoms at birth and sequelae. Clin Infect Dis 51:33–41 [View Article][PubMed]
     [Google Scholar]
  25. Poole E., Walther A., Raven K., Benedict C. A., Mason G. M., Sinclair J. 2013; The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner. J Virol 87:4261–4271 [View Article][PubMed]
     [Google Scholar]
  26. Ranganathan P., Clark P. A., Kuo J. S., Salamat M. S., Kalejta R. F. 2012; Significant association of multiple human cytomegalovirus genomic loci with glioblastoma multiforme samples. J Virol 86:854–864 [View Article][PubMed]
     [Google Scholar]
  27. Sinclair J., Sissons P. 2006; Latency and reactivation of human cytomegalovirus. J Gen Virol 87:1763–1779 [View Article][PubMed]
     [Google Scholar]
  28. Söderberg-Nauclér C., Rahbar A., Stragliotto G. 2013; Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med 369:985–986 [View Article][PubMed]
     [Google Scholar]
  29. Stragliotto G., Rahbar A., Solberg N. W., Lilja A., Taher C., Orrego A., Bjurman B., Tammik C., Skarman P., other authors. 2013; Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study. Int J Cancer 133:1204–1213 [View Article][PubMed]
     [Google Scholar]
  30. Taher C., de Boniface J., Mohammad A. A., Religa P., Hartman J., Yaiw K. C., Frisell J., Rahbar A., Söderberg-Naucler C. 2013; High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes. PLoS One 8:e56795 [View Article][PubMed]
     [Google Scholar]
  31. Taher C., Frisk G., Fuentes S., Religa P., Costa H., Assinger A., Vetvik K. K., Bukholm I. R., Yaiw K. C., other authors. 2014; High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers. Transl Oncol 7:732–740 [View Article][PubMed]
     [Google Scholar]
  32. Tanaka K., Numazaki K., Tsutsumi H. 2005; Human cytomegalovirus genetic variability in strains isolated from Japanese children during 1983-2003. J Med Virol 76:356–360 [View Article][PubMed]
     [Google Scholar]
  33. Watts T. H., Gommerman J. L. 2005; The LIGHT and DARC sides of herpesvirus entry mediator. Proc Natl Acad Sci U S A 102:13365–13366 [View Article][PubMed]
     [Google Scholar]
  34. Wolmer-Solberg N., Baryawno N., Rahbar A., Fuchs D., Odeberg J., Taher C., Wilhelmi V., Milosevic J., Mohammad A. A., other authors. 2013; Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target?. Int J Cancer 133:2351–2361 [View Article][PubMed]
     [Google Scholar]
  35. Wu K. G., Hung M. C., Chang Y. T., Chen C. J., Yang S. P., Liu C. Y., Ho D. M., Chan Y. J. 2011; Occurrence of human cytomegalovirus glycoprotein B genotypes in immunocompetent and immunosuppressed Taiwanese patients. Intervirology 54:196–201 [View Article][PubMed]
     [Google Scholar]
  36. Yan H., Koyano S., Inami Y., Yamamoto Y., Suzutani T., Mizuguchi M., Ushijima H., Kurane I., Inoue N. 2008; Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children. Arch Virol 153:667–674 [View Article][PubMed]
     [Google Scholar]
  37. Zipeto D., Hong C., Gerna G., Zavattoni M., Katzenstein D., Merigan T. C., Rasmussen L. 1998; Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients. AIDS Res Hum Retroviruses 14:533–536 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000308
Loading
Genetic polymorphisms of the human cytomegalovirus UL144 gene in colorectal cancer and its association with clinical outcome
J. Gen. Virol. 96, 3613 (2015); https://doi.org/10.1099/jgv.0.000308
/content/journal/jgv/10.1099/jgv.0.000308
/content/journal/jgv/10.1099/jgv.0.000308
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error